FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2733289507> ?p ?o ?g. }

• W2733289507 abstract "9025 Background: Tissue biopsy is the gold standard for detection of genomic alterations (GA) and selection of matched targeted therapies in NSCLC, but ctDNA assay provides a possible complementary approach for some pts. Methods: Hybrid-capture based genomic profiling of 62 genes using a ctDNA assay (FoundationACT™) was performed on blood samples from 1,019 consecutive NSCLC pts. The fraction of ctDNA in the blood was estimated using the maximum somatic allele frequency (MSAF) for each sample. Results: Pt characteristics: Median age 69 years (range 8-94); 54% were female. Histologies included adenocarcinoma (n = 720), NSCLC not otherwise specified (NSCLC NOS; n = 179), squamous cell (n = 57), LC NOS (n = 51), large cell (n = 6), and sarcomatoid (n = 6). ≥1 reportable GA was detected in 71% of all cases and in 83% of cases with evidence of ctDNA in the blood (MSAF > 0). For 22 pts with paired blood and tissue samples collected within 30 days and MSAF > 0, 33/64 (52%) GA detected in tissue were also detected in ctDNA. In 55 pts for whom tissue was insufficient for analysis, ≥1 GA was detected in ctDNA in 43 (78%) cases. For 856 cases with MSAF > 0, an average of 1.8 GA/sample were reported. GA were most frequently detected in TP53 (57%), EGFR (23%) and KRAS (17%). Comparative analysis with the tissue-based FoundationCORE™ database (n = 19,264) showed similar frequencies of GA per gene, although KRAS mutation was more frequent in tissue than ctDNA (27% vs 17%, P < 0.0001), and EGFR T790M was more frequent in ctDNA than tissue (7% vs 2%, P < 0.0001), likely reflecting use of liquid versus tissue biopsy after relapse on targeted therapy .Kinase fusions ( ALK, ROS1, RET, FGFR3, PDGFRA) were identified in 5% (39/856) of cases. Diverse and novel mechanisms of acquired resistance (AR) were detected in ctDNA including MET Y1230C and EGFR amplification post-crizotinib, FGFR3-TACC3 fusion post-EGFR inhibitor, and multiple EGFRAR mutations post-osimertinib. Conclusions: In this series, use of a rigorously validated capture-based assay revealed evidence of ctDNA in the blood in 84% of cases. Our results provide clinical support for use of this assay as a complementary technology to tissue-based genomic testing in a subset of pts with NSCLC." @default.
• W2733289507 created "2017-07-14" @default.
• W2733289507 creator A5002494853 @default.
• W2733289507 creator A5006246286 @default.
• W2733289507 creator A5011609796 @default.
• W2733289507 creator A5018054038 @default.
• W2733289507 creator A5035120516 @default.
• W2733289507 creator A5037214933 @default.
• W2733289507 creator A5062019987 @default.
• W2733289507 creator A5077391276 @default.
• W2733289507 creator A5078798686 @default.
• W2733289507 creator A5080311196 @default.
• W2733289507 creator A5080831388 @default.
• W2733289507 creator A5087923582 @default.
• W2733289507 creator A5088559019 @default.
• W2733289507 creator A5088809839 @default.
• W2733289507 date "2017-05-20" @default.
• W2733289507 modified "2023-09-23" @default.
• W2733289507 title "Genomic profiling of circulating tumor DNA (ctDNA) from patients (pts) with advanced non-small cell lung cancer (NSCLC)." @default.
• W2733289507 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.9025" @default.
• W2733289507 hasPublicationYear "2017" @default.
• W2733289507 type Work @default.
• W2733289507 sameAs 2733289507 @default.
• W2733289507 citedByCount "1" @default.
• W2733289507 countsByYear W27332895072018 @default.
• W2733289507 crossrefType "journal-article" @default.
• W2733289507 hasAuthorship W2733289507A5002494853 @default.
• W2733289507 hasAuthorship W2733289507A5006246286 @default.
• W2733289507 hasAuthorship W2733289507A5011609796 @default.
• W2733289507 hasAuthorship W2733289507A5018054038 @default.
• W2733289507 hasAuthorship W2733289507A5035120516 @default.
• W2733289507 hasAuthorship W2733289507A5037214933 @default.
• W2733289507 hasAuthorship W2733289507A5062019987 @default.
• W2733289507 hasAuthorship W2733289507A5077391276 @default.
• W2733289507 hasAuthorship W2733289507A5078798686 @default.
• W2733289507 hasAuthorship W2733289507A5080311196 @default.
• W2733289507 hasAuthorship W2733289507A5080831388 @default.
• W2733289507 hasAuthorship W2733289507A5087923582 @default.
• W2733289507 hasAuthorship W2733289507A5088559019 @default.
• W2733289507 hasAuthorship W2733289507A5088809839 @default.
• W2733289507 hasConcept C121608353 @default.
• W2733289507 hasConcept C126322002 @default.
• W2733289507 hasConcept C143998085 @default.
• W2733289507 hasConcept C2776256026 @default.
• W2733289507 hasConcept C2781335228 @default.
• W2733289507 hasConcept C502942594 @default.
• W2733289507 hasConcept C54355233 @default.
• W2733289507 hasConcept C552990157 @default.
• W2733289507 hasConcept C71924100 @default.
• W2733289507 hasConcept C79386861 @default.
• W2733289507 hasConcept C86803240 @default.
• W2733289507 hasConceptScore W2733289507C121608353 @default.
• W2733289507 hasConceptScore W2733289507C126322002 @default.
• W2733289507 hasConceptScore W2733289507C143998085 @default.
• W2733289507 hasConceptScore W2733289507C2776256026 @default.
• W2733289507 hasConceptScore W2733289507C2781335228 @default.
• W2733289507 hasConceptScore W2733289507C502942594 @default.
• W2733289507 hasConceptScore W2733289507C54355233 @default.
• W2733289507 hasConceptScore W2733289507C552990157 @default.
• W2733289507 hasConceptScore W2733289507C71924100 @default.
• W2733289507 hasConceptScore W2733289507C79386861 @default.
• W2733289507 hasConceptScore W2733289507C86803240 @default.
• W2733289507 hasLocation W27332895071 @default.
• W2733289507 hasOpenAccess W2733289507 @default.
• W2733289507 hasPrimaryLocation W27332895071 @default.
• W2733289507 hasRelatedWork W2767391322 @default.
• W2733289507 hasRelatedWork W2770927717 @default.
• W2733289507 hasRelatedWork W2791189080 @default.
• W2733289507 hasRelatedWork W2890538295 @default.
• W2733289507 hasRelatedWork W2890654515 @default.
• W2733289507 hasRelatedWork W2891496010 @default.
• W2733289507 hasRelatedWork W2941690366 @default.
• W2733289507 hasRelatedWork W2947153214 @default.
• W2733289507 hasRelatedWork W2947753084 @default.
• W2733289507 hasRelatedWork W2951707953 @default.
• W2733289507 hasRelatedWork W2952662079 @default.
• W2733289507 hasRelatedWork W2991390854 @default.
• W2733289507 hasRelatedWork W3007734467 @default.
• W2733289507 hasRelatedWork W3016686226 @default.
• W2733289507 hasRelatedWork W3028772519 @default.
• W2733289507 hasRelatedWork W3089024688 @default.
• W2733289507 hasRelatedWork W3130023215 @default.
• W2733289507 hasRelatedWork W3161666351 @default.
• W2733289507 hasRelatedWork W3164117097 @default.
• W2733289507 hasRelatedWork W3189368770 @default.
• W2733289507 isParatext "false" @default.
• W2733289507 isRetracted "false" @default.
• W2733289507 magId "2733289507" @default.
• W2733289507 workType "article" @default.